Clinical Trials
8
Trial Phases
2 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (8 trials with phase data)• Click on a phase to view related trials
A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic Dermatitis
- Conditions
- Atopic DermatitisAtopic Dermatitis EczemaEczema
- Interventions
- Drug: Placebo
- First Posted Date
- 2025-06-26
- Last Posted Date
- 2025-08-03
- Lead Sponsor
- Inmagene LLC
- Target Recruit Count
- 220
- Registration Number
- NCT07037901
- Locations
- 🇺🇸
Forest Hills Dermatology Group, Kew Gardens, New York, United States
🇺🇸Apex Clinical Research Center, Mayfield Heights, Ohio, United States
🇺🇸Dermatology of Seattle & Bellevue, Burien, Washington, United States
Safety and Pharmacokinetics of Subcutaneous Dose of IMG-007 in Healthy Participants
- First Posted Date
- 2024-03-12
- Last Posted Date
- 2024-12-12
- Lead Sponsor
- Inmagene LLC
- Target Recruit Count
- 24
- Registration Number
- NCT06304740
- Locations
- 🇦🇺
Linear Clinical Research, Perth, Australia
A Study to Evaluate the Safety, Pharmacokinetics and Efficacy of IMG-007 in Adult Alopecia Areata Participants
- First Posted Date
- 2023-09-29
- Last Posted Date
- 2025-04-30
- Lead Sponsor
- Inmagene LLC
- Target Recruit Count
- 29
- Registration Number
- NCT06060977
- Locations
- 🇺🇸
Northwest Arkansas Clinical Trials Center, PLLC/ Hull Dermatology P.A., Rogers, Arkansas, United States
🇺🇸Torrance Clinical Research Institute Inc., Lomita, California, United States
🇺🇸Alliance Clinical Research of Tampa, Tampa, Florida, United States
A Study to Evaluate the Safety, Pharmacokinetics, and Efficacy of IMG-007 in Adults With Atopic Dermatitis (AD)
- Conditions
- Moderate-to-severe Atopic DermatitisAtopic DermatitisAD
- Interventions
- Drug: Placebo
- First Posted Date
- 2023-08-09
- Last Posted Date
- 2024-12-24
- Lead Sponsor
- Inmagene LLC
- Target Recruit Count
- 13
- Registration Number
- NCT05984784
- Locations
- 🇺🇸
Amicis Research Center, Valencia, California, United States
🇺🇸Medical Research Center of Miami II Inc, Miami, Florida, United States
🇺🇸Optimal Research Sites, Orange City, Florida, United States
Evaluate IMG-007 in Healthy Participants
- Conditions
- Healthy Participants
- Interventions
- Drug: IMG-007 or placebo
- First Posted Date
- 2022-04-29
- Last Posted Date
- 2023-06-28
- Lead Sponsor
- Inmagene LLC
- Target Recruit Count
- 44
- Registration Number
- NCT05353972
- Locations
- 🇦🇺
Linear Clinical Research, Nedlands, Western Australia, Australia
- Prev
- 1
- 2
- Next